Related Experiment Video
Updated: Feb 5, 2026

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
Mitochondrial Peroxynitrite Mediation of Anthracycline-Induced Cardiotoxicity as Visualized by a Two-Photon
Xilei Xie1, Fuyan Tang1, Guangzhao Liu1
1College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science , Shandong Normal University , Jinan 250014 , PR China.
Abstract:
Anthracyclines rank among the most efficacious anticancer medications. However, their clinical utility and oncologic efficacy are severely compromised by the cardiotoxicity risk facing the early-diagnosis difficulty and their unclear molecular mechanism. Herein, a two-photon-excitable and near-infrared-emissive fluorescent probe, TPNIR-FP, was fabricated and endowed with extraordinary specificity and sensitivity and a rapid response toward peroxynitrite (ONOO-), as well as mitochondria-targeting ability. With the aid of TPNIR-FP, we demonstrate that mitochondrial ONOO- is upregulated in the early stage and contributes to the onset and progression of anthracycline cardiotoxicity in cardiomyocyte and mouse models; therefore, it represents an early biomarker to predict subclinical cardiotoxicity induced by drug challenge. Furthermore, TPNIR-FP is proved to be a robust imaging tool to provide critical insights into drug-induced cardiotoxicity and other ONOO--related pathophysiological processes.
Insights
Anthracycline chemotherapy can cause heart damage. A new fluorescent probe detects early mitochondrial peroxynitrite (ONOO-) buildup, identifying cardiotoxicity risk before symptoms appear.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Molecular Imaging
Background:
- Anthracyclines are potent anticancer drugs but cause cardiotoxicity.
- Early diagnosis and understanding the mechanism of anthracycline cardiotoxicity remain challenging.
- Mitochondrial dysfunction is implicated in drug-induced heart damage.
Purpose of the Study:
- To develop a novel fluorescent probe for detecting peroxynitrite (ONOO-).
- To investigate the role of mitochondrial ONOO- in anthracycline cardiotoxicity.
- To establish ONOO- as an early biomarker for subclinical cardiotoxicity.
Main Methods:
- Fabrication of a two-photon-excitable, near-infrared-emissive fluorescent probe (TPNIR-FP).
- Demonstration of TPNIR-FP's specificity, sensitivity, and rapid response to ONOO-.
- Utilizing TPNIR-FP in cardiomyocyte and mouse models to monitor mitochondrial ONOO- levels.
Main Results:
- TPNIR-FP exhibits high specificity and sensitivity for ONOO- with mitochondria-targeting ability.
- Mitochondrial ONOO- levels were found to be upregulated in the early stages of anthracycline treatment.
- Increased ONOO- correlated with the onset and progression of cardiotoxicity in experimental models.
Conclusions:
- Mitochondrial peroxynitrite is a key contributor to anthracycline cardiotoxicity.
- TPNIR-FP serves as a valuable tool for early detection of cardiotoxicity.
- This probe offers insights into ONOO--related pathophysiological processes.
Related Concept Videos
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Export of Mitochondrial and Chloroplast Genes
Receptor-mediated Endocytosis
The Inner Mitochondrial Membrane
Infrared (IR) Spectroscopy: Overview
Different compounds display unique properties due to their...

